How much dividend does ImmuCell pay?
Over the past 12 months, ImmuCell paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ImmuCell is expected to pay a dividend of 0 USD.
ImmuCell Dividend 2024
ImmuCell Dividend
0 USD
ImmuCell Dividend yield
Ticker
ICCC
ISIN
US4525253062
WKN
885825
How much dividend does ImmuCell 2024 pay?
According to the latest status from July 2024, ImmuCell paid a total of 0 USD per share in dividends within the last 12 months. With the current ImmuCell price of 4.17 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical ImmuCell Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Is the ImmuCell Dividend Safe?
ImmuCell has been increasing the dividend for 0 years.
Over the past 10 years, ImmuCell has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding ImmuCell's Dividend Distributions
ImmuCell’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining ImmuCell's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
ImmuCell's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in ImmuCell’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
ImmuCell Aktienanalyse
What does ImmuCell do?
ImmuCell Corp is an American company that specializes in the development and marketing of veterinary products for the ruminant industry. It was originally founded in the late 1970s under the name PrioGene and initially focused on the development of diagnostics for tuberculosis and brucellosis in cattle. In the 1990s, the company changed its name to ImmuCell and shifted its focus to the development of products to support animal health. ImmuCell's business model is centered around the development, manufacturing, and sale of products to improve animal health. They offer a wide range of veterinary products, including immunoassays, vaccines, antibiotics, and complementary feeds. The company aims to improve animal health with minimal impact on the environment and works closely with veterinarians and industry experts. They have divisions dedicated to diagnostics, vaccines, and antibiotics, and their products can help identify and prevent diseases in livestock. Notable products include the LBC mastitis diagnostic and the Immu-PRIME spray for preventing umbilical infections in newborn calves. ImmuCell has established itself as a leading innovator in the animal health industry and has conducted clinical studies on the efficacy of their HO-VAX product. In conclusion, ImmuCell focuses on developing and marketing products to support animal health, with a commitment to improving the well-being of livestock. ImmuCell is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about ImmuCell stock
What is the dividend yield of ImmuCell?
The current dividend yield of ImmuCell is .
When does ImmuCell pay dividends?
ImmuCell pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of ImmuCell?
ImmuCell paid dividends every year for the past 0 years.
What is the dividend of ImmuCell?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is ImmuCell located?
ImmuCell is assigned to the 'Health' sector.
Wann musste ich die Aktien von ImmuCell kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ImmuCell from 7/31/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.
When did ImmuCell pay the last dividend?
The last dividend was paid out on 7/31/2024.
What was the dividend of ImmuCell in the year 2023?
In the year 2023, ImmuCell distributed 0 USD as dividends.
In which currency does ImmuCell pay out the dividend?
The dividends of ImmuCell are distributed in USD.
Andere Kennzahlen von ImmuCell
Our stock analysis for ImmuCell Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ImmuCell Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
